Literature DB >> 24599033

Amino acid-PEGylated resveratrol and its influence on solubility and the controlled release behavior.

Yue Zhang1, Haiwen Song, Zhenhua Shang, Aibing Chen, Daowei Huang, Hua Zhao, Hongxia Du.   

Abstract

A set of polyethylene glycol (PEG)-resveratrol (RES) conjugates with amino acid as spacers was designed and synthesized to improve certain defects of resveratrol, such as poor solubility, its short half-life and the difficulty of obtaining controlled release. Amino acids, which are released along with RES, are necessary for human health and likely have a facilitating effect on the absorption of the drug. The prepared PEG conjugates were characterized by FT-IR, (1)H-NMR, X-ray diffraction (XRD) and differential scanning calorimetry (DSC). Evaluation of free RES, loading capability, solubility and in vitro release of conjugates was also conducted. The results show that solubility in water of all the conjugates is over 900 mg·mL(-1) and controlled release of RES was achieved. Therefore, the developed PEG conjugate is a favorable system for modifying the solubility and bioavailability of RES.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599033     DOI: 10.1248/bpb.b13-00863

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Synthesis, characterization and in vitro release performance of the pegylated valnemulin prodrug.

Authors:  Xinrui Dong; Xueye Shu; Yingnan Wang; Zhaohuan Niu; Shixia Xu; Yue Zhang; Shuchun Zhao
Journal:  J Vet Med Sci       Date:  2017-11-28       Impact factor: 1.267

2.  Chitosan-modified hollow manganese dioxide nanoparticles loaded with resveratrol for the treatment of spinal cord injury.

Authors:  Yingqiao Li; Zhiru Zou; Jinyu An; Qian Wu; Le Tong; Xifan Mei; He Tian; Chao Wu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 3.  Neuroprotective effects of resveratrol in Alzheimer disease pathology.

Authors:  Shraddha D Rege; Thangiah Geetha; Gerald D Griffin; Tom L Broderick; Jeganathan Ramesh Babu
Journal:  Front Aging Neurosci       Date:  2014-09-11       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.